References
- Bidstrup TB, Bjørnsdottir I, Sidelmann UG, et al. (2003). CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. Br J Clin Pharmacol 56:305–14
- Busby WF Jr, Ackermann JM, Crespi CL. (1999). Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug Metab Dispos 27:246–9
- Crespi CL. (1998). Effect of salt concentration on the activity of liver microsomal and cDNA-expressed human cytochromes P450. Available from: http://www.researchgate.net/publication/238741518 [last accessed 6 Jul 2015]
- Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–5
- Eberts FS Jr, Philopoulos Y, Reineke LM, et al. (1981). Triazolam disposition. Clin Pharmacol Ther 29:81–93
- Houston JB, Kenworthy KE. (2000). In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metab Dispos 28:246–54
- Iwatsubo T, Hirota N, Ooie T, et al. (1997). Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther 73:147–71
- Karonen T, Filppula A, Laitila J, et al. (2010). Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast. Clin Pharmacol Ther 88:223–30
- Mäenpää J, Hall SD, Ring BJ, et al. (1998). Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. Pharmacogenetics 8:137–55
- Mück W. (2000). Clinical pharmacokinetics of cerivastatin. Clin Pharmacokinet 39:99–116
- Niemi M, Backman JT, Neuvonen M, et al. (2003a). Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide. Diabetologia 46:347–51
- Niemi M, Leathart JB, Neuvonen M, et al. (2003b). Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide. Clin Pharmacol Ther 74:380–7
- Pearce R, Greenway D, Parkinson A. (1992). Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch Biochem Biophys 298:211–25
- Perloff MD, von Moltke LL, Court MH, et al. (2000). Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. J Pharmacol Exp Ther 292:618–28
- Prueksaritanont T, Ma B, Yu N. (2003). The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br J Clin Pharmacol 56:120–4
- Rahman A, Korzekwa KR, Grogan J, et al. (1994). Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8. Cancer Res 54:5543–6
- Rodríguez-Antona C, Niemi M, Backman JT, et al. (2008). Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism. Pharmacogenomics J 8:268–77
- Tornio A, Niemi M, Neuvonen PJ, et al. (2008). Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone. Drug Metab Dispos 36:73–80
- Venkatakrishnan K, Von Moltke LL, Greenblatt DJ. (2001). Human drug metabolism and the cytochromes P450: application and relevance of in vitro models. J Clin Pharmacol 41:1149–79
- Yamaoka K, Tanigawara Y, Nakagawa T, et al. (1981). A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879–85
- Yuan R, Flockhart DA, Balian JD. (1999). Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam. J Clin Pharmacol 39:1109–25
- Yun CH, Ahn T, Guengerich FP. (1998). Conformational change and activation of cytochrome P450 2B1 induced by salt and phospholipid. Arch Biochem Biophys 356:229–38
- Yun CH, Song M, Ahn T, et al. (1996). Conformational change of cytochrome P450 1A2 induced by sodium chloride. J Biol Chem 271:31312–16